LAUSR

Metabolic chemical reporters (MCRs) of protein glycosylation are analogues of natural monosaccharides that bear reactive groups, like azides and alkynes. When they are added to living cells and organisms, these small molecules are biosynthetically transformed into nucleotide donor sugars and then used by glycosyltransferases to modify proteins. Subsequent installation of tags by bioorthogonal chemistries can then enable the visualization and enrichment of these glycoproteins. Although this two‐step procedure is powerful, the use of MCRs has the potential to change the endogenous production of the natural repertoire of donor sugars. A major route for the generation of these glycosyltransferase substrates is the hexosamine biosynthetic pathway (HBP), which results in uridine diphosphate N‐acetylglucosamine (UDP‐GlcNAc). Interestingly, the rate‐determining enzyme of the HBP, glutamine fructose‐6‐phosphate amidotransferase (GFAT), is feedback inhibited by UDP‐GlcNAc. This raises the possibility that a build‐up of UDP‐MCRs would block the biosynthesis of UDP‐GlcNAc, resulting in off target effects. Here, we directly test this possibility with recombinant human GFAT and a small panel of synthetic UDP‐MCRs. We find that MCRs with larger substitutions at the N‐acetyl position do not inhibit GFAT, whereas those with modifications of the 2‐ or 6‐hydroxy group do. These results further illuminate the considerations that should be applied to the use of MCRs.